LGR5 and colorectal carcinoma: We used tamoxifen treatment to show specific deletion of PKM2 in GFP-expressing Lgr5+ ISC and their progeny (Fig. S1) and a combination of AOM and DSS treatment to induce inflammation-derived CRC (Fig. 2a).